Partnership
IHI Corporation x GE Aerospace (GEnx Engine Partnership)
IHI is a risk and revenue sharing partner in GE's GEnx engine program, jointly developing and producing the high-bypass turbofan engine for civil aircraft. IHI has a long-standing relationship with GE Aerospace across multiple engine programs including the Passport engine.
development · Active · operating
Machine-readable surfaces
- Markdown mirror: /partnerships/ihi-corporation-x-ge-aerospace-genx-engine-partnership.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/partnerships/ihi-corporation-x-ge-aerospace-genx-engine-partnership
- Revision history: /partnerships/ihi-corporation-x-ge-aerospace-genx-engine-partnership/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
1f5039a5-3e08-48eb-8d67-64d17de8a4da- Type
- development
- Status
- Activeoperating
Who’s involved
IHI Corporationco developer
IHI Corporation (TSE: 7013) is a Japanese heavy industrial manufacturer producing aircraft engines, turbochargers, and industrial machinery. Develops automated manufacturing systems and robotics for aerospace and [Energy](/companies/energy-robotics) industries.
Most-frequent partners
Off-registry parties
- GE Aerospace · co developer
Related partnerships
Other deals between the same parties
- technology—just announced
- development—operating
Other partnerships of IHI Corporation
- technology—just announced
- development—operating
Recent partnerships of the same kind
- Kautex Textron RESiLiTE Horizon EuropeKautex Textron + Horizon Europe EU Programmedevelopment—operating
- Canvas x USG CorporationCanvas + USG Corporationdevelopment—operating
- Threod Systems x First ShieldFirst Shield + Threod Systemsdevelopment—operating
- RIKEN BDR x Otsuka Pharmaceutical CollaborationRIKEN Center for Biosystems Dynamics + Otsuka Pharmaceuticaldevelopment—operating
- Entegris x SEMATECHEntegris + SEMATECHdevelopment—operating
- development—operating
Sources (1)
Deploy Watch
Track this partnership.
We notify you when the status changes against primary-source evidence, expansion is verified, or the partnership is terminated.